VaxGen, Inc.

VaxGen, Inc. - S. San Francisco, CA; originally spun-off from Genentech to develop its candidate HIV vaccine; VaxGen is the largest shareholder in Celltrion, a S. Korean contract manufacturing joint venture; VaxGen was acquired by OXiGENE in late 2009

Related product monographs:

1. Anthrax Vaccine, rDNA -- Manuf. ; R&D ; Tech. ; Former
2. CTLA4-Ig, rDNA -- Parent

Location - S. San Francisco CA USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute